Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m

Oct 6, 2024 - 04:00

Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m

Read the original article

Tags:

Previous Article

Can You Lose Weight With Vitamin B12?

WuXi debates sale of pharma operations as BIOSECURE Act advances

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Most drugmakers have so far ignored looming FTC deadline to withdraw or amend wayward patents

Most drugmakers have so far ignored looming FTC deadlin...

Dec 7, 2023

GoodRx hires former tech exec as CEO, Amazon shutters Halo, and Teladoc beats expectations

GoodRx hires former tech exec as CEO, Amazon shutters H...

Apr 27, 2023

Lawmakers circle parents’ rights in gender-affirming care hearing

Lawmakers circle parents’ rights in gender-affirming ca...

Jul 28, 2023